351 related articles for article (PubMed ID: 17305928)
41. [High prevalence of subclinical thyroidal disease among individuals attended in health control].
Fardella C; Poggi H; Gloger S; Rojas A; Velasquez CG; Barroileth S; Figueroa R; Alvarez C; Salgado C; Gajardo C; Foradori A; Montero J
Rev Med Chil; 2001 Feb; 129(2):155-60. PubMed ID: 11351466
[TBL] [Abstract][Full Text] [Related]
42. [Cardiovascular consequences of thyroid diseases, their prevalence and treatment, particularly in cases with subclinical hyper- and hypothyroidism].
Molnár I
Orv Hetil; 2005 Oct; 146(40):2067-72. PubMed ID: 16259335
[TBL] [Abstract][Full Text] [Related]
43. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
Bolhaar MG; Karstaedt AS
Clin Infect Dis; 2007 Jul; 45(2):254-60. PubMed ID: 17578788
[TBL] [Abstract][Full Text] [Related]
44. Clinically evident thyroid gland disorders in Lublin Region.
Mardarowicz G; Lopatyński J; Szydłowski W
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):462-5. PubMed ID: 15323237
[TBL] [Abstract][Full Text] [Related]
45. Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study.
Martin F; Taylor GP
J Infect Dis; 2007 Aug; 196(4):558-61. PubMed ID: 17624841
[TBL] [Abstract][Full Text] [Related]
46. [Clinical analysis of 339 cases of thyroid-associated ophthalmopathy].
He JF; Wu ZY; Yang HS; Yan JH; Mao YX; Chen ZC; Ai SM
Zhonghua Yan Ke Za Zhi; 2004 Jun; 40(6):368-72. PubMed ID: 15312599
[TBL] [Abstract][Full Text] [Related]
47. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
[TBL] [Abstract][Full Text] [Related]
48. The study of thyroid diseases in a community not using iodized salt.
Teng X; Hu F; Teng W; Wang H; Shong S; Shan Z; Jin Y; Guan H; Yang F; Gao T; Wang W; Shi X; Teng D
Zhonghua Yu Fang Yi Xue Za Zhi; 2002 May; 36(3):176-9. PubMed ID: 12410951
[TBL] [Abstract][Full Text] [Related]
49. [Interferon-alpha-induced disorders of thyroid function. A retrospective analysis of the literature and personal experiences].
Weissel M; Templ E; Gisslinger H
Acta Med Austriaca; 1995; 22(1-2):1-5. PubMed ID: 7645363
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of thyroid dysfunction in Thai HIV-infected patients.
Ketsamathi C; Jongjaroenprasert W; Chailurkit LO; Udomsubpayakul U; Kiertiburanakul S
Curr HIV Res; 2006 Oct; 4(4):463-7. PubMed ID: 17073621
[TBL] [Abstract][Full Text] [Related]
51. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
[TBL] [Abstract][Full Text] [Related]
52. Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir.
Crane HM; Kestenbaum B; Harrington RD; Kitahata MM
AIDS; 2007 Jul; 21(11):1431-9. PubMed ID: 17589189
[TBL] [Abstract][Full Text] [Related]
53. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
[TBL] [Abstract][Full Text] [Related]
54. [Screening for thyroid disorders in elderly patients].
Torre R; Del Monte P; Bernasconi D; Marugo A; Poggi P; Leoncini R; Marugo M
Recenti Prog Med; 2004 Jun; 95(6):308-11. PubMed ID: 15248413
[TBL] [Abstract][Full Text] [Related]
55. Thyroid function in patients with proteinuria.
Gilles R; den Heijer M; Ross AH; Sweep FC; Hermus AR; Wetzels JF
Neth J Med; 2008 Dec; 66(11):483-5. PubMed ID: 19075315
[TBL] [Abstract][Full Text] [Related]
56. Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study.
Di Giambenedetto S; Bracciale L; Colafigli M; Cattani P; Pinnetti C; Bacarelli A; Prosperi M; Fadda G; Cauda R; De Luca A
Antivir Ther; 2007; 12(5):835-9. PubMed ID: 17713168
[TBL] [Abstract][Full Text] [Related]
57. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
58. [Thyroid dysfunction and thyroid antibodies in a population group over the age of 70. A prevalence study from Oslo and Naeröy].
Bjøro T; Frey HM; Larsen IF; Brochmann H; Hanson F; Gaarder PI
Tidsskr Nor Laegeforen; 1989 Apr; 109(10):1048-51. PubMed ID: 2786266
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of thyroid dysfunction and its correlation with CD4 count in newly-diagnosed HIV-positive adults--a cross-sectional study.
Dev N; Sahoo R; Kulshreshtha B; Gadpayle AK; Sharma SC
Int J STD AIDS; 2015 Nov; 26(13):965-70. PubMed ID: 25505045
[TBL] [Abstract][Full Text] [Related]
60. [Long-term study of subclinical hypothyroidism: spontaneous course and predictors of manifest hypothyroidism].
Huber G; Mitrache C; Meier C; Guglielmetti M; Huber P; Staub JJ
Schweiz Med Wochenschr; 1998 Nov; 128(48):1902-5. PubMed ID: 9879618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
